|
"楊志新"的相關文件
顯示項目 126-175 / 209 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pernetrexed Versus Pemetrexed as 2nd-Line Therapy in Patients with Advanced Nsclc: A Randomized, Double-Blind Phase Iii Trial ( Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
An Open-Label Single-Arm Phase Iv Study of Pemetrexed in Taiwanese Patients with Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy
|
張基晟; 蔡俊明; 夏德椿; 楊志新; CHANG, GEE-CHEN; TSAI, CHUN-MING; HSIA, TE-CHUN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Melatonin Inhibits Arsenite-Induced Peripheral Neurotoxicity
|
林滿玉; 范素芬; 趙珮玲; 楊志新; LIN, A. MAAN-YUH; FANG, SU-FEN; CHAO, PEI -LING; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Comparison of Epidermal Growth Factor Receptor Mutations between Primary and Corresponding Metastatic Tumors in Tyrosine Kinase Inhibitor-Naive Non -Small-Cell Lung Cancer
|
高劍虹; 張逸良; 蔡孟峰; 吳振都; 余忠仁; 楊志新; 李元麒; 楊泮池; 施金元; GOW, CHIEN-HUNG; CHANG, YIH-LEONG; TSAI, MENG-FENG; WU, CHEN-TU; YU, CHONG-JEN; YANG, CHIH-HSIN; LEE, YUNG-CHIE; YANG, PAN-CHYR; SHIH, JIN-YUAN |
| 國立臺灣大學 |
2009 |
Egfr Intron 1 Dinucleotide Repeat Polymorphism Is Associated with the Occurrence of Skin Rash with Gefitinib Treatment
|
黃敬倫; 楊志新; 葉坤輝; 胡賦强; 陳冠宇; 施金元; 林宗哲; 余忠仁; 鄭安理; 楊泮池; HUANG, CHING-LUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; HU, FU-CHANG; CHEN, KUAN-YU; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2009 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Elderly or Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer
|
林家齊; 楊志新; LIN, CHIA-CHI; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital
|
林家齊; 楊志新; 鄭安理; 陳榮楷; 何弘能; LIN, CHIA-CHI; YANG, CHIH-HSIN; CHENG, ANN-LII; CHAN, WING-KAI; HO, HONG-NERNG |
| 國立臺灣大學 |
2009 |
Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Receiving First-Line Gefitinib Monotherapy
|
邵幼雲; 林宗哲; 胡賦强; 余忠仁; 施金元; 胡文郁; 張逸良; 鄭安理; 楊泮池; 楊志新; SHAO, YU-YUN; LIN, ZONG-ZHE; HU, FU-CHANG; YU, CHONG-JEN; SHIH, JIN-YUAN; HU, WEN-YU; CHANG, YIH-LEONG; CHENG, ANN-LII; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Bibw 2992, a Novel Irreversible Dual Egfr and Her2 Tyrosine Kinase Inhibitor (Tki), in Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations after Failure of One Line of Chemotherapy (Lux-Lung 2)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Biomarker Analyses from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib (G) Versus Carboplatin/Paclitaxel (C/P) in Clinically Selected Patients (Pts) with Advanced Non-Small Cell Lung Cancer (Nsclc) in Asia (Ipass)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Efficacy of Pemetrexed-Cisplatin (Pc) in East Asian Patients (Pts): Subgroup Analysis of a Phase Iii Study Comparing Pc Versus Gemcitabine- Cisplatin (Gc) in First-Line Treatment of Advanced Non-Small Cell Lung Cancer (Nsclc)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Phase Iib/Iii Double-Blind Randomized Trial of Bibw 2992, an Irreversible, Dual Inhibitor of Egfr and Her2 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc in Patients with Nsclc Failing 1-2 Lines of Chemotherapy (Ct) and Erlotinib or Gefitinib (Lu
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S |
| 國立臺灣大學 |
2008-07-31 |
非小細胞肺癌對表皮生長因子接受器抑制劑抗藥性之研究 （新制多年期第1年）
|
楊志新 |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 中國醫藥大學 |
2008-03-29 |
肺癌病人接受根治性胸腔放療之預後
|
簡君儒(Chun-Ru Chien); 楊志新; 余忠仁* |
| 國立臺灣大學 |
2008-01 |
Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response
|
Gow, Chien-Hung; Chien, Chun-Ru; Chang, Yih-Leong; Chiu, Yueh-Hsia; Kuo, Sung-Hsin; Shih, Jin-Yuan; Chang, Yeun-Chung; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 高劍虹; 簡君儒; 張逸良; 邱月瑕; 郭頌鑫; 施金元; 張允中; 余忠仁; 楊志新; 楊泮池 |
| 國立臺灣大學 |
2008 |
Caveolin-1 Expression Is Significantly Associated with Drug Resistance and Poor Prognosis in Advanced Non-Small Cell Lung Cancer Patients Treated with Gemcitabine-Based Chemotherapy
|
何肇基; 郭頌鑫; 黃佩欣; 黃馨儀; 楊志新; 楊泮池; HO, CHAO-CHI; KUO, SUNG-HSIN; HUANG, PEI-HSIN; HUANG, HSIN-YI; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2008 |
Acute Encephalopathy Following Arsenic Trioxide for Metastatic Urothelial Carcinoma
|
林家齊; 蒲永孝; 徐志宏; 耿孝宜; 鄭安理; 楊志新; LIN, CHIA-CHI; PU, YEONG-SHIAU; HSU, CHIH-HUNG; KENG, HSIAO-YI; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial
|
許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Predictors of Toxicity of Weekly Docetaxel in Chemotherapy-Treated Non- Small Cell Lung Cancers
|
陳若白; 羅英; 余忠仁; 許駿; 施金元; 楊志新; CHEN, JO-PAI; LO, YIN; YU, CHONG-JEN; HSU, CHIUN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, CHIH- HSIN |
| 國立臺灣大學 |
2008 |
Frequent Epidermal Growth Factor Receptor Gene Mutations in Malignant Pleural Effusion of Lung Adenocarcinoma
|
吳尚俊; 高劍虹; 余忠仁; 張逸良; 楊志新; 施金元; 李元麒; 楊泮池; WU, SHANG-GIN; GOW, CHIEN-HUNG; YU, CHONG-JEN; CHANG, YIH-LEONG; YANG, CHIH-HSIN; SHIH, JIN-YUAN; LEE, YUNG-CHIE; YANG, PAN-CHYR |
| 國立臺灣大學 |
2008 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (Egfr) Mutations with the Classical Mutation Pattern
|
吳尚俊; 張逸良; 巫震宇; 楊志新; 余忠仁; 蔡孟峰; 施金元; 楊泮池; WU, SHANG-GIN; CHANG, YIH-LEONG; WU, JENN-YU; YANG, CHIH-HSIN; YU, CHONG-JEN; TSAI, MENG-FENG; SHIH, JIN-YUAN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2007-07-31 |
非小細胞肺癌對表皮生長因子接受器抑制劑抗藥性之研究 （新制多年期第2年）
|
楊志新 |
| 國立臺灣大學 |
2007 |
A Phase II Study of Oral Vinorelbine in Combination with Cisplatin Conducted in Taiwan in Patients with Unresectable Localized or Metastatic Non-Small Cell Lung Carcinoma
|
陳育民; 余忠仁; 楊志新; 彭瑞鵬; 蔡俊明; 施振甫; 鄭安理; 楊泮池; CHEN, YU-MING; YU, CHONG-JEN; YANG, CHIH-HSIN; PENG, JUI-PENG; TSAI, CHUN-MING; SHIH, JEN-FU; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2007 |
Concurrent Chemoradiotherapy with Twice Weekly Paclitaxel and Cisplatin Followed by Esophagectomy for Locally Advanced Esophageal Cancer
|
林家齊; 徐志宏; 王秀伯; 李章銘; 葉坤輝; 楊志新; 林肇堂; 鄭安理; 李元麒; LIN, CHIA-CHI; HSU, CHIH-HUNG; WANG, HSIU-PO; LE,E JANG-MING; YEH, KUN-HUEI; YANG, CHIH-HSIN; LIN, JAW-TOWN; CHENG, ANN-LII; LEE, YUNG-CHIE |
| 國立臺灣大學 |
2007 |
Arsenic Trioxide in Patients with Hepatocellular Carcinoma: A Phase Ii Trial
|
林家齊; 許駿; 徐志宏; 許瑋玲; 鄭安理; 楊志新; LIN, CHIA-CHI; HSU, CHIUN; HSU, CHIH-HUNG; HSU, WEI-LING; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
A Phase Ii Trial of Weekly Paclitaxel and High-Dose 5-Fluorouracil Plus Leucovorin in Patients with Chemotherapy-Pretreated Metastatic Breast Cancer
|
林家齊; 鄭安理; 徐志宏; 盧彥伸; 許駿; 葉坤輝; 吳貞瑤; 黃俊升; 楊志新; LIN, CHIA-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; LU, YEN-SHEN; HSU, CHIUN; YEH, KUN-HUEI; WU, CHEN-YAO; HUANG, CHIUN-SHENG; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
Endoplasmic Reticulum Stress Is Involved in Arsenite-Induced Oxidative Injury in Rat Brain
|
林滿玉; 戚謹文; 楊志新; LIN, MAAN-YUH; CHI, CHIN-WEN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
Melatonin Attenuates Arsenite-Induced Apoptosis in Rat Brain: Involvement of Mitochondrial and Endoplasmic Reticulum Pathways and Aggregation of Alpha-Synuclein
|
林滿玉; 楊志新; LIN, MAAN-YUH; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
Revisit of 1997 Tnm Staging System - Survival Analysis of 1112 Lung Cancer Patients in Taiwan
|
彭瑞鵬; 陳姿怡; 張基晟; 夏德椿; 蔡英煌; 蔡俊明; 楊志新; 陳育民; 余忠仁; 李仁智; 邱昭華; PENG, JUI-PENG; CHEN, CHIH-YI; CHANG, GEE-CHEN; HSIA, TE-CHUN; TSAI, YING-HUANG; TSAI, CHUN-MING; YANG, CHIH-HSIN; CHEN, YU-MING; YU, CHONG-JEN; LEE, JEN-JYH; CHIU, CHAO-HUA |
| 國立臺灣大學 |
2007 |
Interim Safety Results from the East/South East (E/Se) Asian Subgroup of the Open-Label Trust (Tarceva Lung Cancer Survival Treatment) Study of Erlotinib for Advanced Non-Small-Cell Lung Cancer (Nsclc)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
Met Amplification Occurs with or without T790m Mutations in Egfr Mutant Lung Tumors with Acquired Resistance to Gefitinib or Erlotinib
|
施金元; 張文誠; 余忠仁; 黃秀芬; 楊泮池; 楊志新; SHIH, JIN-YUAN; CHANG, WEN-CHENG; YU, CHONG-JEN; HUANG, SHIU-FENG; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2006 |
癌症的第四種治療：生物製劑治療
|
楊志新 |
| 國立臺灣大學 |
2006 |
Epidermal Growth Factor Receptor Mutations in Needle Biopsy/Aspiration Samples Predict Response to Gefitinib Therapy and Survival of Patients with Advanced Nonsmall Cell Lung Cancer
|
施金元; 高劍虹; 余忠仁; 楊志新; 張逸良; 蔡孟峰; 陳冠宇; 蘇文彬; 楊泮池; SHIH, JIN-YUAN; GOW, CHIEN-HUNG; YU, CHONG-JEN; YANG, CHIH-HSIN; CHANG, YIH-LEONG; TSAI, MENG-FENG; CHEN, KUAN-YU; SU, WEN-PIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2006 |
Predictive Factors of Gefitinib Antitumor Activity in East Asian Advanced Non-Small Cell Lung Cancer Patients
|
張基晟; 蔡俊明; 陳焜結; 余忠仁; 施金元; 楊宗穎; 林京珮; 許正園; 邱昭華; 彭瑞鵬; 楊泮池; 楊志新; CHANG, GEE-CHEN; TSAI, CHUN-MING; CHEN, KUN-CHIEH; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, TSUNG-YING; LIN, CHING-PEI; HSU, JENG- YUAN; CHIU, CHAO-HUA; PENG, JUI-PENG; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2006 |
A Phase Ii Study of Gefitinib as First Line Treatment for Good Performance Advanced or Metastatic Non-Small Cell Lung Cancer in East Asian Patients
|
楊志新; 余忠仁; 陳焜結; 林宗哲; 郭頌鑫; 鄭安理; 楊泮池; YANG, CHIH-HSIN; YU, CHONG-JEN; CHEN, KUN-CHIEH; LIN, ZHONG-ZHE; KUO, SUNG-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2006 |
Survival Outcome and Predictors of Gefitinib Antitumor Activity in East Asian Chemonaive Patients with Advanced Nonsmall Cell Lung Cancer
|
楊志新; 施金元; 陳焜結; 余忠仁; 楊宗穎; 林京珮; 蘇文彬; 高劍虹; 許駿; 張基晟; 楊泮池; YANG, CHIH-HSIN; SHIH, JIN-YUAN; CHEN, KUN-CHIEH; YU, CHONG-JEN; YANG, TSUNG-YING; LIN, CHING-PEI; SU, WEN-PIN; GOW, CHIEN-HUNG; HSU, CHIUN; CHANG, GEE-CHEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2006 |
Thoracic Radiotherapy for Stage Iv Non-Small Cell Lung Cancer
|
簡君儒; 楊志新; CHIEN, CHUN-RU; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2005 |
低氧對小鼠腫瘤生長及抗藥性之影響-建立動物模式(2/3)
|
楊志新 |
| 國立臺灣大學 |
2005 |
Docetaxel-Induced Recall Dermatitis on Previous Laser Treatment Sites
|
朱家瑜; 楊志新; CHU, CHIA-YU; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2005 |
A Phase Ii Study in Taiwan with Navelbine(Nvb) Oral in Combinatino with Cisplatin (C) in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients
|
余忠仁; 楊志新; 鄭安理; 楊泮池; YU, CHONG-JEN; YANG, CHIH-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Survival of Stage Iiib/Iv Non-Small Cell Lung Cancer Patients Who Received Chemotherapy but Did Not Participate in Clinical Trials
|
郭頌鑫; 楊志新; 余忠仁; 許駿; 鄭安理; 楊泮池; KUO, SUNG-HSIN; YANG, CHIH-HSIN; YU, CHONG-JEN; HSU, CHIUN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Intrapatient Dose Escalation to 800 Mg/M2 Pemetrexed Is Safe and Feasible in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc) Who Have Had Prior Chemotherapy
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2005 |
Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment
|
楊志新; 陳明君; 鄭安理; 徐志宏; 葉坤輝; 汪彭嘉康; 楊泮池; YANG, CHIH-HSIN; CHEN, MIN-CHUN; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; JACQUELINE, WHANG-PENG; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Gefitinib Reverses Chemotherapy Resistance in Gefitinib-Insensitive Multidrug Resistant Cancer Cells Expressing Atp-Binding Cassette Family Protein
|
楊志新; 黃靜如; 楊朝順; 朱玉娟; 鄭安理; 彭汪嘉康; 楊泮池; YANG, CHIH-HSIN; HUANG, CHING-JU; YANG, CHAO-SHUN; CHU, YU-CHUAN; CHENG, ANN-LII; WHANG-PENG, JACQUELINE; YANG, PAN-CHYR |
顯示項目 126-175 / 209 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
